Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07632339 · RECRUITING
Trial details
- NCT number
- NCT07632339
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2028-06-16
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.